The data displays the leading female contraceptive vendors in the U.S. in 2016, based on sales. In that year, Duramed Pharmaceuticals was the leading female contraceptive vendor in the U.S. with sales of 182.7 million USD. Total sales of U.S. female contraceptive vendors amounted to 330.5 million USD in 2016.
Duramed Pharmaceuticals |
182.7 |
Teva Women's Health |
116.4 |
Gavis Pharmaceuticals | 16.4 |
Watson Pharmaceuticals |
4.9 |
Apothecus | 4.1 |
Revive Personal Products | 2.8 |
Mayer Laboratories | 1 |
Blairex Laboratories | 0.9 |
Lupin Pharmaceuticals | 0.3 |
Private Label | 0.3 |